Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.

Author: CalderonJ, RubinE, SobotaW L

Paper Details 
Original Abstract of the Article :
Sialorrhea is reported by 31% of patients taking clozapine. Anticholinergic agents and adrenergic agonists are used for its treatment based on empirical evidence. In the present study, 10 patients who failed to respond to anticholinergic or adrenergic agents received intranasal ipatropium bromide (I...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00004850-200015010-00008

データ提供:米国国立医学図書館(NLM)

Intranasal Ipatropium Bromide: A Potential Treatment for Clozapine-Induced Hypersalivation

Clozapine, an effective antipsychotic medication, can sometimes cause excessive salivation, known as hypersalivation. This study explores the potential of intranasal ipatropium bromide as a treatment option for managing this side effect. The study utilizes a [research method] to evaluate the efficacy of intranasal ipatropium bromide in reducing hypersalivation in individuals taking clozapine. The study demonstrates that intranasal ipatropium bromide might be a promising treatment option for clozapine-induced hypersalivation. The key findings include [key findings].

A Targeted Approach to Hypersalivation Management

The results of this study suggest that intranasal ipatropium bromide could offer a more targeted approach to managing clozapine-induced hypersalivation, minimizing systemic side effects. The study found that [quantifiable results], highlighting the potential benefits of this treatment strategy. This could provide a significant improvement in the quality of life for individuals taking clozapine who experience excessive salivation.

Navigating the Desert of Medication Side Effects

Managing medication side effects can feel like navigating a vast and unforgiving desert. While this study suggests that intranasal ipatropium bromide might be a valuable tool for managing hypersalivation, it is crucial to consult with a healthcare professional to determine the most appropriate treatment plan for you. They can assess your individual needs, discuss potential risks and benefits, and recommend the best approach for managing your medication side effects.

Dr.Camel's Conclusion

Intranasal ipatropium bromide, like a skillful guide navigating a treacherous desert path, offers potential relief from clozapine-induced hypersalivation. This study provides encouraging evidence, prompting further investigation into its efficacy and long-term safety. Remember, open communication with your healthcare professional is key to navigating the challenges of medication side effects and ensuring your overall well-being.
Date :
  1. Date Completed 2000-09-25
  2. Date Revised 2019-10-25
Further Info :

Pubmed ID

10836287

DOI: Digital Object Identifier

10.1097/00004850-200015010-00008

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.